News

GlaxoSmithKline (GSK) said that it is the first time the European Commission has approved a non-prescription product for weight loss. The centrally approved marketing authorization means GSK can

Mr Keltjens will succeed Eamonn Hobbs, a co-founder of AngioDynamics, who has led the company for the past 21 years and will become vice chairman of the board

PharmaSurgics patented drug candidate PXL01, has demonstrated an excellent effect and safety profile in preclinical studies and the first clinical trial on patients are planned to start in

The FlexStent femoropopliteal self expanding stent system is indicated for the treatment of peripheral vascular lesions involving the superficial femoral and popliteal arteries. The fully connected flexible FlexStent

The new kits are optimized for characterization of proteins in the MEK and ERK families, which play critical roles in cancer cell survival and proliferation. Drug developers have

Highmark and Independence Blue Cross (IBC) have submitted the applications to the Pennsylvania Insurance Department (PID) in April 2007. In a joint statement, Kenneth Melani, president and CEO

The site has a new purpose-built, 100-bed facility designed to run clinical pharmacology studies in healthy, diabetic and obese participants. Well-known for conducting first-in-human, proof-of-concept studies and participating

Further, Corbett and ltf Labortechnik filed an intervention in opposition proceedings before the European Patent Office. QIAGEN acquired Corbett, an Australian instrumentation manufacturing company, in July 2008. In

Pursuant to the terms of the agreement, Medline will serve as the group’s primary distributor providing medical and surgical products and services. The agreement will focus on driving